This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tachieda, R. Articles by Nakamura, M. Search for Related Content PubMed PubMed Citation Articles by Tachieda, R. Articles by Nakamura, M. Social Bookmarking                         What's this?

Circulating Biochemical Marker Levels of Collagen Metabolism Are Abnormal in Patients with Abdominal Aortic Aneurysm

Hiroyuki Niinuma, MD

Atsushi Ohira, MD

Shigeatsu Endoh, MD

Katsuhiko Hiramori, MD

Shinji Makita, MD, FACA

Motoyuki Nakamura, MD

Second Department of Internal Medicine Iwate Medical University 19-1 Uchimaru Morioka, Iwate 020-8505 Japan

Changes in extracellular matrix composition induced by abnormal collagen metabolism in the aortic wall may be an important factor in the progression of aortic structural changes. The authors have measured several types of biochemical marker for collagen metabolism in plasma: carboxyterminal propeptide of type I collagen (PICP) for a pure collagen synthesis marker, matrix metalloproteinase-1 (MMP-1) for a degradation marker of collagen matrix, and tissue inhibitors of metalloproteinase-1 (TIMP-1) as a native inhibitor of MMP-1. Subjects of this study were 17 patients with abdominal aortic aneurysm (AAA), 14 patients with atherosclerosis obliterans (ASO), and 22 age/sex matched healthy controls (HC). Blood samples were drawn from a forearm vein and measured by radioimmunoassay or enzyme-linked immunosorbent assay. Plasma concen trations of PICP in patients with AAA were significantly decreased compared to those in HC patients (82.0 ±16.4 vs 111.3 ±40.3 ng/mL; p<0.01), but those in patients with ASO (105.4 ±55.4 ng/mL) were comparable to control concentrations. Although no differences in plasma concentrations of MMP-1 were observed among the three subject groups (HC, 20.0 ± 5.6 ng/mL; ASO, 21.4 ± 13.8 ng/mL; AAA, 24.5 ±11.7 ng/mL; NS), MMP-1/PICP ratio as an index of collagen degradation to collagen neosynthesis in AAA was significantly elevated compared to HC (0.32 ±0.18 vs 0.20 ±0.08; p < 0.01). Plasma concentrations of TIMP-1 in patients with AAA (293.8 ±61.2 ng/mL) or ASO (327.6 ±54.9 ng/mL) were significantly higher than in HC (227.3 ±60.2 ng/mL; both p < 0.01). In conclusion, these data suggest that although a compensatory mechanism such as increased TIMP-1 may be activated, collagen neosynthesis may decrease with relatively increased collagen degradation in patients with AAA.

Angiology, Vol. 51, No. 5, 385-392 (2000)
DOI: 10.1177/000331970005100505


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?